Please check your internet connection and try again.
# Lorazepam (representative benzodiazepine)
## Overview
Lorazepam is a benzodiazepine with anxiolytic, sedative, hypnotic, amnestic, and anticonvulsant properties.
## Primary Indications
* Anxiety disorders
* Insomnia
* Status epilepticus (acute treatment)
* Premedication for surgical procedures
* Management of acute agitation
## Adult Dosing
* **Anxiety:** 0.5 mg to 2 mg orally every 6 to 8 hours as needed. Doses may be increased based on response, up to a maximum of 10 mg per day.
* **Insomnia:** 1 mg to 2 mg orally at bedtime.
* **Status Epilepticus:** 2 mg to 4 mg IV or IM initially. May repeat dose once after 10 to 15 minutes if needed. Maximum initial dose is 8 mg.
* **Premedication:** 2 mg to 4 mg orally or IM 2 hours before surgery, or 1 mg to 2 mg IV 15 to 30 minutes before induction of anesthesia.
* **Acute Agitation:** 0.5 mg to 2 mg IV, IM, or orally. Dosing is highly individualized based on the severity of agitation.
## Pediatric Dosing
Dosing in pediatric patients is less established and should be guided by expert consultation or specific institutional protocols.
* **Status Epilepticus:**
* **IV:** 0.05 mg/kg per dose, not to exceed 2 mg per dose. May be repeated once after 10 to 15 minutes.
* **IM:** 0.1 mg/kg per dose, not to exceed 4 mg per dose.
* **Sedation/Anxiety:** Dosing is highly variable and depends on indication, age, and weight.
## Dose Adjustments
* **Hepatic Impairment:** Use with caution; dose reduction may be necessary.
* **Renal Impairment:** No specific dose adjustment recommended, but use with caution.
* **Elderly:** Start with lower doses (e.g., 0.5 mg to 1 mg orally) and titrate slowly due to increased sensitivity to CNS effects and risk of falls.
## Contraindications
* Known hypersensitivity to benzodiazepines or any component of the formulation.
* Acute narrow-angle glaucoma.
* Severe respiratory insufficiency.
* Severe hepatic insufficiency.
* Myasthenia gravis.
* Sleep apnea syndrome.
## Adverse Effects
Common: Drowsiness, dizziness, weakness, unsteadiness, fatigue, confusion.
Less common: Paradoxical reactions (excitement, hallucinations), amnesia, respiratory depression, hypotension.
## Key Drug Interactions
* **CNS Depressants (e.g., opioids, alcohol, other sedatives):** Increased risk of profound sedation, respiratory depression, coma, and death.
* **Theophylline/Aminophylline:** May decrease the sedative effects of lorazepam.
* **Valproic acid:** May increase lorazepam levels.
## Monitoring
* For acute indications: Monitor vital signs (respiratory rate, blood pressure, heart rate), level of consciousness, and signs of paradoxical reactions.
* For chronic use: Monitor for efficacy, dose-dependent side effects, and signs of tolerance or dependence.
## Clinical Pearls
* Lorazepam has a relatively intermediate half-life compared to other benzodiazepines.
* Intramuscular absorption can be variable.
* Intravenous administration should be slow to minimize risk of respiratory depression and hypotension.
* Avoid abrupt discontinuation due to risk of withdrawal symptoms. Tapering is recommended.
* The risk of dependence and abuse increases with prolonged use.
***
*This information is intended for clinical use and does not replace a thorough review of the current prescribing information and relevant literature. Always verify current drug information with a reliable source before making clinical decisions.*
